Skip to content

Evaluation of a Microprocessor-controlled Prosthetic Knee-ankle System (SPCM)

Evaluation of a Microprocessor-controlled Prosthetic Knee-ankle System (SPCM)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06522646
Acronym
SPCM
Enrollment
12
Registered
2024-07-26
Start date
2018-07-09
Completion date
2023-05-31
Last updated
2024-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amputation, Lower Limb Amputation Above Knee (Injury)

Brief summary

The main aim of this study is to compare the adaptation capabilities of the microprocessor-controlled knee-ankle prosthesis system with the comparator covered by the French LPPR, known as the usual prosthesis. The main hypothesis being that wearing the SPCM increases the time spent flat-footed in the various walking situations of everyday life, bringing it closer to that of asymptomatic people. This is a prospective, multicenter, randomized, cross-over study. The participants are transfemoral amputees who have been fitted with a microprocessor-controlled prosthetic knee for more than 3 months.

Interventions

DEVICESPCM

During a period of 4-6 weeks, patients will live in their usual environment with the SPCM prosthesis

DEVICEUsual Prothesis

During a period of 4-6 weeks, patients will live in their usual environment with their usual microprocessor prosthesis

Sponsors

Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est
CollaboratorOTHER
Hopital d'instruction des armées Percy (HIA Percy)
CollaboratorUNKNOWN
Proteor Group
CollaboratorINDUSTRY
Direction Générale de l'Armement
CollaboratorUNKNOWN
Institution Nationale des Invalides
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Amputee at or above knee level * Person fitted for more than 3 months with a microprocessor-controlled knee support phase and oscillating phase, in accordance with the conditions for reimbursement set out in the LPPR. * Person with a level of activity according to the International Classification of of Functioning, Disability and Health greater than or equal to d4602 (moving around outside the house and other buildings) * Person able to understand simple commands, to read and write, and to give their informed consent * Person who has given informed consent * Person affiliated to a social security scheme

Exclusion criteria

* Minor * Person of full age subject to a legal protection measure or unable to express consent * Pregnant or breast-feeding women * Persons with bilateral amputations * Person with a neurological or orthopedic pathology with major repercussions on locomotion * Persons with a ground/knee height of less than 43.5 cm or more than 55 cm * Persons weighing more than 125 kg * Foot size less than 24 cm or greater than 30 cm * Person with a hip disarticulation * Person without an emergency walking solution * Person with a suspension fitting with vacuum pump * Person planning a trip outside Europe or unable to return in less than 24 hours (in case of device failure) for the duration of the protocol.

Design outcomes

Primary

MeasureTime frameDescription
Comparison of the time (measured as a percentage of the gait cycle) when the foot is flat on the ground during walking in three gait situations: flat, on a slope and going down stairs, with SPCM and the usual prosthesis.Evaluation after 4 weeks' wear of each of the 2 prosthesesThe aim is to compare the adaptation of the prosthetic system to the constraints of everyday life. SPCM adapts the ankle's behavior to the walking situation, and should make it possible to restore the time during which the foot remains flat during the stance phase, in different situations

Secondary

MeasureTime frameDescription
Pelvis elevationEvaluation after 4 weeks' wear of each of the 2 prosthesesPelvis elevation is a locomotor compensation device used by transfemoral amputees. It is a biomechanical parameter usually measured by quantified motion analysis (AQM). The SPCM prosthetic system is expected to reduce these Pelvis elevation.
Toe clearanceEvaluation after 4 weeks' wear of each of the 2 prosthesesToe clearance is the distance between the toe of the foot and the ground during the swing phase. The greater this distance, the safer the patient. With SPCM, the toe clearance should increase, providing greater safety during pitch change in the swing phase.
Prosthesis evaluationEvaluation after 4 weeks' wear of each of the 2 prosthesesThe PEQ is composed of 9 validated scales that are each comprised of multiple questions, and there are a number of additional individual questions. Each question is rated between 0 and 100. Higher number will correspond with a more positive response.
Locomotor abilitiesEvaluation after 4 weeks' wear of each of the 2 prosthesesIt is composed of 14 questions about different locomotor activities. A 4-level ordinal scale (0-3 points; ranging from not able to able to accomplish the activity alone) scores the degree of a person's perceived independence in performing each of the 14 activities while wearing the prosthesis. The higher the total score, the greater the patient's abilities.
Contralateral ankle powerEvaluation after 4 weeks' wear of each of the 2 prosthesesContralateral ankle power is a locomotor compensation device used by transfemoral amputees. It is a biomechanical parameter usually measured by quantified motion analysis (AQM). The SPCM prosthetic system is expected to reduce these power.
SF-36 QuestionnaireEvaluation after 4 weeks' wear of each of the 2 prosthesesSocre of the SF-36 questionnaire, evaluation of the quality of life. The score range from 0 to 100. A higher score mean a better outcome.
Number of stepsEvaluation after 4 weeks' wear of SPCMQuantifying real-life activity. The aim is to check whether the improvements observed during the laboratory motion analysis test are reflected in real life. Comparison of the number of steps recorded by the prosthesis sensors and those obtained during the laboratory gait analysis. Equivalence between the systems is expected.
CadenceEvaluation after 4 weeks' wear of SPCMQuantifying real-life activity. The aim is to check whether the improvements observed during the laboratory motion analysis test are reflected in real life. Comparison of the cadence recorded by the prosthesis sensors and those obtained during the laboratory gait analysis. Equivalence between the systems is expected.
MobilityEvaluation after 4 weeks' wear of each of the 2 prosthesesThe Prosthetic Limb Users Survey of Mobility (PLUS-M) is a self-report instrument for measuring mobility of adults with lower limb amputation. PLUS-M provide a T-score that ranges from 17.5 to 76.6.A higher PLUS-M™ T-score corresponds to greater mobility.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026